Peroneal electrical Transcutaneous NeuroModulation as a new treatment for patients with overactive bladder: an initial clinical experience
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F22%3AE0109639" target="_blank" >RIV/00843989:_____/22:E0109639 - isvavai.cz</a>
Alternative codes found
RIV/00064203:_____/22:10442141 RIV/00216208:11130/22:10442141 RIV/61988987:17110/22:A2302J4Y
Result on the web
<a href="https://www.karger.com/Article/FullText/522570" target="_blank" >https://www.karger.com/Article/FullText/522570</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1159/000522570" target="_blank" >10.1159/000522570</a>
Alternative languages
Result language
angličtina
Original language name
Peroneal electrical Transcutaneous NeuroModulation as a new treatment for patients with overactive bladder: an initial clinical experience
Original language description
Introduction: The aim of this study was to determine whether peroneal electrical Transcutaneous NeuroModulation (peroneal eTNM®) using the URIS® neuromodulation system can be used in individuals with refractory overactive bladder (OAB). Methods: Eighteen female patients with idiopathic OAB who failed previous behavioral and pharmacological therapy were enrolled. Patients were treated with the URIS® neuromodulation system using active electrodes placed on the popliteal fossa, targeting the peroneal nerve for 30 min once a week for 12 weeks. Changes in OAB symptoms and patient-reported outcomes from baseline to the end of the study were analyzed. A nonparametric Wilcoxon signed-rank test was used to assess changes in variables. Statistical significance was defined as p ? 0.05. Results: We observed a significant reduction in micturition frequency (p = 0.022), number of severe urgency episodes (p < 0.001), urgency incontinence episodes (p = 0.001), and nocturia episodes (p = 0.027). A decrease in Patient Perception of Bladder Condition score (p < 0.001) was also observed. Posttreatment, 15 patients (83.3%) reported a moderate or significant reduction in their bladder bother. Throughout the study, two adverse events were recorded with no causal relationship to the study treatment. Discussion/conclusions: Our study documented a significant reduction in all OAB symptoms and an improvement in all patient-reported outcomes in patients treated with peroneal eTNM® using the URIS® neuromodulation system.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30217 - Urology and nephrology
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Urologia Internationalis
ISSN
0042-1138
e-ISSN
1423-0399
Volume of the periodical
106
Issue of the periodical within the volume
7
Country of publishing house
CH - SWITZERLAND
Number of pages
6
Pages from-to
658-663
UT code for WoS article
000777307100001
EID of the result in the Scopus database
2-s2.0-85127835769